HEART FAILURE WITH MID RANGE EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MID RANGE EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MID RANGE EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MID RANGE EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common diabetes pill ease rare heart condition?
Disease control CompletedThis study tested the drug dapagliflozin (a diabetes medicine) in 50 adults with heart failure due to amyloid cardiomyopathy, a rare condition where abnormal proteins stiffen the heart. Researchers measured changes in quality of life, walking ability, and heart stress levels over…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Phase: NA • Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New MRI scan could spot hidden heart disease in seniors
Diagnosis CompletedThis study tested whether a special heart MRI scan (T1 mapping) can accurately diagnose cardiac amyloidosis, a condition where abnormal proteins build up in the heart. Researchers studied 112 older adults with heart failure and thickened heart walls. The goal was to see if this s…
Matched conditions: HEART FAILURE WITH MID RANGE EJECTION FRACTION
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 26, 2026 04:38 UTC